Recruiting OBSERVATIONAL NCT07314268
ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers (EV-ATTR)
Sponsor: InCor Heart Institute
Conditions
Amyloidosis Cardiac Amyloidosis Transthyretin Amyloidosis, Hereditary Wild-type ATTR Amyloidosis
Updated 1 time since 2026 Last updated: Dec 16, 2025 Started: Oct 18, 2024 Primary completion: May 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Amyloidosis Cardiac and Amyloidosis Transthyretin, this trial is actively recruiting participants. The trial is conducted by InCor Heart Institute and has accumulated 1 data snapshot since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- InCor Heart Institute
- University of Sao Paulo General Hospital
Data source: University of Sao Paulo General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .